logo-loader
viewArcher Materials Ltd

Full interview: Archer Materials lodges graphene biosensor technology international patent application

Archer Materials Limited (ASX:AXE) chief executive officer Dr Mohammad Choucair updates Proactive on the filing of an international patent application to commercialise the company’s ground-breaking graphene biosensor technology and protect its international property.

Archer is a leader in developing technology for the use of graphene materials for human health, which could provide potential solutions, for example, to rapid, highly sensitive and portable testing for in-vitro diagnostics.

The company’s biosensor technology is unique in that it uses digital manufacturing to print critical ultrasensitive graphene material components that are integrated into one of a number of sensors.

Quick facts: Archer Materials Ltd

Price: 0.17 AUD

ASX:AXE
Market: ASX
Market Cap: $36.11 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Archer Materials Ltd named herein, including the promotion by the Company of Archer Materials Ltd in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Archer Materials on track to build operational...

Archer Materials Ltd (ASX:AXE) chief executive officer Mohammad Choucair speaks to Proactive about how the company is performing quantum measurements required to build an operational room-temperature qubit processor chip.  Archer is one of very few companies globally that provides...

3 weeks, 1 day ago

2 min read